Picture of Theravance Biopharma logo

TBPH Theravance Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

U.S. RESEARCH ROUNDUP:-Cisco, GXO Logistics, Theravance Biopharma

Sept 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.listed companies, including Cisco, GXO Logistics and Theravance Biopharma on
Thursday. 
    
    HIGHLIGHTS
     * Cisco  CSCO.O : Credit Suisse raises to outperform from neutral
     * GXO Logistics Inc  GXO.N : JP Morgan initiates coverage with overweight rating
     * Theravance Biopharma Inc  TBPH.O : Needham cuts to hold from buy 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order. 

     * Actinium Pharmaceuticals Inc  ATNM.A : Alliance Global Partners cuts PT to $20 from $25 
     * Beyond Meat Inc  BYND.O : Piper Sandler cuts to underweight from neutral
     * Beyond Meat Inc  BYND.O : Piper Sandler cuts target price to $95 from $120 
     * California Resources Corp  CRC.N : Keybanc raises target price to $47 from $45 
     * Chipotle Mexican Grill Inc  CMG.N : Piper Sandler raises target to $2,600 from $2,235 
     * Cisco  CSCO.O : Credit Suisse raises target price to $74 from $56 
     * Cisco  CSCO.O : Credit Suisse raises to outperform from neutral 
     * Cisco  CSCO.O : Evercore ISI raises target price to $67 from $63 
     * Cisco  CSCO.O : Jefferies raises target price to $65 from $63 
     * Cisco  CSCO.O : JP Morgan raises target price to $70 from $67 
     * Cisco  CSCO.O : Piper Sandler raises target price to $57 from $53 
     * Continental Resources Inc  CLR.N : Keybanc raises target price to $46 from $41 
     * Core & Main Inc  CNM.N : Truist Securities raises target price to $30 from $29 
     * Cortexyme Inc  CRTX.O : Canaccord Genuity raises target price to $150 from $75 
     * Crinetics Pharmaceuticals Inc  CRNX.O : JP Morgan raises target price to $37 from $34 
     * Delek US Holdings Inc  DK.N : Piper Sandler raises target price to $30 from $27 
     * Ezcorp Inc  EZPW.O : Oppenheimer initiates with outperform rating and target of $12 
     * Greensky Inc  GSKY.O : Stephens raises target price to $12 from $6 
     * GXO Logistics Inc  GXO.N : JP Morgan initiates coverage with overweight rating 
     * GXO Logistics Inc  GXO.N : JP Morgan initiates coverage with $107 price target 
     * Healthpeak Properties Inc  PEAK.N : Jefferies raises target price to $34 from $31 
     * Las Vegas Sands Corp  LVS.N : JP Morgan cuts target price to $38 from $59 
     * Las Vegas Sands Corp  LVS.N : JP Morgan cuts to neutral from overweight 
     * Magnolia Oil & Gas Corp  MGY.N : Keybanc raises target price to $18 from $17 
     * Marathon Petroleum Corp  MPC.N : Piper Sandler raises target price to $69 from $66 
     * Pacira Biosciences Inc  PCRX.O : Needham cuts target price to $80 from $82 
     * Par Pacific Holdings Inc  PARR.N : Piper Sandler raises target price to $17 from $14 
     * Phillips 66  PSX.N : Piper Sandler cuts target price to $85 from $92 
     * Theravance Biopharma Inc  TBPH.O : Cowen and Company cuts target price to $8 from $14 
     * Theravance Biopharma Inc  TBPH.O : Evercore ISI cuts target price to $14 from $21 
     * Theravance Biopharma Inc  TBPH.O : JP Morgan cuts to underweight from overweight
     * Theravance Biopharma Inc  TBPH.O : JP Morgan cuts price target to $7 from $17 
     * Theravance Biopharma Inc  TBPH.O : Needham cuts to hold from buy 
     * Timken Co  TKR.N : Jefferies cuts target price to $100 from $110 
     * Valero Energy Corp  VLO.N : Piper Sandler cuts target price to $75 from $81 
     * Ventas Inc  VTR.N : Jefferies raises target price to $53 from $52 
     * Welltower Inc  WELL.N : Jefferies raises target price to $82 from $78 
     * Wynn Resorts Ltd  WYNN.O : JP Morgan cuts target price to $89 from $122 
     * Wynn Resorts Ltd  WYNN.O : JP Morgan cuts to neutral from overweight 
     * XPO Logistics Inc  XPO.N : JP Morgan cuts target price to $113 from $171 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Theravance Biopharma

See all news